BBK Worldwide Blog

HYBRID: A New Approach for Clinical Trial Recruitment & Engagement Success

Posted by Elizabeth Gargill

Introducing a New Approach to Clinical Trial Recruitment & Engagement

 

Our hybrid approach to clinical trial recruitment and engagement provides sponsors with the flexibility and agility they need whether they are conducting a traditional site-based trial, hybrid trial, or decentralized trial. 

Read More

Topics: TrialCentralNet, Decentralized Clinical Trials, Decentralized Solutions, Hybrid Clinical Trials, Hybrid, TCN

Facilitating the Journey from Patient to Study Participant

Posted by Elizabeth Gargill

Pharma15 Live!

Facilitating the Journey from Patient to Study Participant

The Impact of Dynamic Referral Processing

Matt Kibby and Aaron Fleishman return to the Pharma15 Live! stage to discuss BBK's dynamic referral processing service and how it improves and accelerates the patient enrollment process. 

"Our process benefits both patients and sites alike. It unburdens the study staff, creating a better experience for them, while also ensuring patients are responded to more quickly and with better care so their journey is a positive one."

-Matt Kibby, President, Chief Strategy Officer, BBK Worldwide

Watch Now

Read More

Topics: Pharma15 Live!, Call Centers, Matt Kibby, Aaron Fleishman, Hybrid Clinical Trials, Dynamic Referral Processing, Secondary Prescreening

Words Matter: The Hybrid Lexicon

Posted by Gaby Grekin

 

 

Words Matter: The Hybrid Lexicon

 

In a time of confusing terminology, one thing is clear: what the industry used to consider exceptional is now considered essential.

 

Hybrid. Decentralized. Remote. Digital. Virtual. Companies use these terms interchangeably. There is inconsistency, over-hyping, over-promising, confusion and a notable lack of substance. To be honest, it’s a bit like the Wild West out there.

Read More

Topics: Digital, Virtual, Decentralized Clinical Trials, Hybrid Clinical Trials, Remote

Study Voices Survey: Patients want choice offered through hybrid enrollment solutions

Posted by Elizabeth Gargill

 

New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.

Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial enrollment models to hybrid enrollment models.

 

DOWNLOAD NOW

Read More

Topics: Most Viewed, Study Voices, Aaron Fleishman, International Clinical Trials, Surveys, Hybrid Clinical Trials

In the Year 2022 and Beyond

We are all hoping that 2022 will be a better year for the world, one where the impact of the pandemic truly begins to subside for everyone around the globe. That said, it is a basic truth that every challenge presents some opportunity, and the impact of COVID-19 on the clinical research and development industry has been no exception.

Read More

Topics: Rob Laurens, Decentralized Clinical Trials, Hybrid Clinical Trials, Crystal Ball, Concierge, Site Centricity

Survey: Patients Want Choice Offered through Hybrid Clinical Trials

Posted by Elizabeth Gargill

New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep participants engaged longer.

When we developed our latest Study Voices survey, we expected to see large gaps in attitudes and experiences among healthcare consumers and clinical trial participants based on factors such as age, race, ethnicity, gender, and income – but that wasn’t the case.

Read More

Topics: Patient Engagement, Study Voices, Surveys, Diversity, Inclusion, Patients, Hybrid Clinical Trials, Whitepaper